Sigma-Tau Industrie Framaceutiche Riunite, S.P.A. v. Lonza, Ltd.

106 F. Supp. 2d 8, 2000 U.S. Dist. LEXIS 12709, 2000 WL 868433
CourtDistrict Court, District of Columbia
DecidedJune 7, 2000
DocketCivil Action 97-0562 JHG/DAR
StatusPublished

This text of 106 F. Supp. 2d 8 (Sigma-Tau Industrie Framaceutiche Riunite, S.P.A. v. Lonza, Ltd.) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sigma-Tau Industrie Framaceutiche Riunite, S.P.A. v. Lonza, Ltd., 106 F. Supp. 2d 8, 2000 U.S. Dist. LEXIS 12709, 2000 WL 868433 (D.D.C. 2000).

Opinion

MEMORANDUM ORDER

DEBORAH ANN ROBINSON, United States Magistrate Judge.

This is a declaratory judgment action in which plaintiffs seek a determination that U.S.Patent No. 5,073,376 (“the ’376 patent”) is invalid and not infringed. During the course of discovery, plaintiffs took the deposition of Stephen Blum, then an employee of defendant and a co-inventor of the patent which plaintiffs have alleged is prior art to the ’376 patent.

After the close of discovery, plaintiffs sought leave to reopen discovery, and to redepose Mr. Blum and conduct follow-up discovery with respect to Blum’s corrections of his deposition testimony. See Plaintiffs’ Motion for Leave to Reopen Discovery to Redepose Stephen Blum and Conduct Discovery of Matters Raised Therein. By an Order entered on July 27, 1998, the trial court granted the motion. The trial court found that “[m]any of the proposed revisions reveal that Mr. Blum did not respond accurately and completely to the questions posed at his deposition[,]” and that “the significantly different answers now proposed by Mr. Blum ... [are] ample justification for plaintiffs’ request to re-depose Mr. Blum.” July 27, 1998 Order at 2. By the same Order, the trial court referred to the undersigned any disputes between the parties regarding the reasonableness of the follow-up discovery. July 27, 1998 Order at 3. In a subsequent Order, the trial court referred to the undersigned for resolution the plaintiffs’ allegations that counsel for defendant caused the re-deposition by instructing Mr. Blum to lie, to withhold information and not to correct his original deposition testimony. September 16, 1998 Order at 2; see Plaintiffs’ Supplemental Opposition to Defendant’s Motion for Partial Reconsideration of the Order Granting Leave to Reopen Discovery to Re-Depose Stephen Blum and Conduct Discovery of Matters Raised Therein at 2-3. These and other allegations of misconduct by both defendant and its counsel were the subject of Plaintiffs’ Motion to Compel Production of Withheld Documents and Testimony Under the Crime-Fraud Exception to the Attorney-Client Privilege and Work Product Immunity Doctrine (Docket No. 117).

During the course of five days in December, 1998, the undersigned heard testimony from six witnesses — including Mr. Blum and Bert Lewen, one of defendant’s counsel — and reviewed 84 exhibits, 58 of which were received into evidence. At the conclusion of the hearing, counsel for the *10 parties met and conferred in accordance with the undersigned’s order. In the written report of their conference, plaintiffs identified seven acts which they alleged were relevant to then." allegations of fraud, all involving conduct by Mr. Lewen with respect to Mr. Blum. See Stipulations of the Parties Regarding Issues Before the Court as a Result of the Hearing Pertaining to [Plaintiffs’] Motion to Compel Production of Documents (Docket No. 138) (“Stipulations”) at 3-4. Plaintiffs withdrew their allegations of fraud against lawyers David Francescani and Maryann Hayes, as well as the various officers and employees of Lonza, Inc. and Lonza AG against whom such allegations were initially made. 1 Stipulations at 4. Plaintiffs also withdrew their allegation that Mr. Lewen committed an act of fraud by taking a position he knew to be incorrect. 2 Stipulations at 5.

Upon consideration of the evidence offered at the hearing, the oral arguments of counsel, the parties’ written submissions and the entire record herein, the undersigned found that no credible evidence was offered in support of plaintiffs’ allegations that Mr. Lewen, through his participation in either the document review at Mr. Blum’s home or the preparation of Mr. Blum for the December, 1997 deposition, committed any fraud on the Court. The undersigned further found that plaintiffs failed to demonstrate that Mr. Blum offered any testimony at his December, 1997 deposition which was false. Finally, the undersigned found that even assuming, ar-guendo, that Mr. Blum willfully offered false testimony during his December, 1997 deposition, plaintiffs did not show that Mr. Lewen knew that Mr. Blum’s testimony was false. More specifically, the undersigned found that Mr. Lewen never directed Mr. Blum to testify falsely; had no knowledge that any testimony offered by Mr. Blum was false; and had no reason to believe that Mr. Blum would testify falsely. On the basis of those findings, the undersigned denied Plaintiffs’ Motion to Compel Production of Withheld Documents and Testimony Under the Crime Fraud Exception to the Attorney-Client Privilege and Work Product Immunity Doctrine. Sigma-Tau Industrie Farmaceutiche Riunite, S.p.A., et al. v. Lonza, Ltd., 48 F.Supp.2d 16 (D.D.C.1999).

By a motion filed on December 6,1999— nearly ten months after the entry of the Order denying plaintiffs’ motion to compel — defendant moves, pursuant to Rule 37(a)(4)(B) of the Federal Rules of Civil Procedure, for entry of an order awarding reasonable fees and expenses incurred in defending plaintiffs’ motion to compel. See Defendant/Counter-Plaintiffs Motion for Fees and Expenses Pursuant to Rule 37(a)(4)(B), Fed.R.CivP (Docket No. 162). In the memorandum in support of its motion, defendant maintains that

[r]epeatedly, Plaintiffs represented to the Court that the entire process of new depositions, additional documentary production and a five-day hearing was necessary in order to obtain critical evidence relating to the patent-in-suit which was kept from them during the initial deposition of Mr. Stephen Blum, Defendant’s former employee. In doing so, Plaintiffs presented a tale of Machiavellian-intrigue, complete with allegations of coercion, conspiracy to commit perjury and double-crossing. Instead, the uncontroverted evidence showed that Mr. Blum’s accusations were nothing more than the ramblings of a deeply troubled individual seeking *11 the proverbial “pound of flesh” from an employer who he felt had betrayed him.

Defendant/Counter-Plaintiffs Memorandum of Law in Support of its Motion for Fees and Expenses Pursuant to Rule 37(a)(4)(B), Fed.R.Civ.P. (“Defendant’s Memorandum”) at 2.

Defendant further maintains that [s]o incredible and nonsensical was Mr. Blum’s testimony that it cannot, in good faith, be argued that Plaintiffs motion contained the requisite “substantial justification” for a bona fide motion to compel under Rule 37, Fed.R.Civ.P. As such, Plaintiffs should be made to bear the expenses, including attorneys fees, incurred by Defendant in opposing this baseless motion.

Defendant’s Memorandum at 3. Defendant submits that “all of the evidence presented by the parties at the hearing was already known to plaintiffs,” and that there was “absolutely no justification to proceed with the hearing after discovery on the matter was taken and there are no circumstances which make an award of expenses unjust.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pierce v. Underwood
487 U.S. 552 (Supreme Court, 1988)
Liew v. Breen
640 F.2d 1046 (Ninth Circuit, 1981)
Sigma-Tau Industrie Farmaceutiche Riunite, S.P.A. v. Lonza, Ltd.
48 F. Supp. 2d 16 (District of Columbia, 1999)
Alexander v. Federal Bureau of Investigation
186 F.R.D. 144 (District of Columbia, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
106 F. Supp. 2d 8, 2000 U.S. Dist. LEXIS 12709, 2000 WL 868433, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sigma-tau-industrie-framaceutiche-riunite-spa-v-lonza-ltd-dcd-2000.